EMA Told to Sharpen Communications

A communications specialist has suggested the European Medicines Agency (EMA) establish a special board to advise on its risk communications.

A communications specialist has suggested the European Medicines Agency (EMA) establish a special board to advise on its risk communications.

Dr Frederic Bouder, of King’s College, University of London, said EMA should also change its information output from one-size-fits-all press releases to messages targeted at audiences, because it has to communicate with non-specialist patients as well as highly trained pharmaceutical and medical professionals.

"Standard documents, e.g. Q&A and press releases, are neither adapted to experts nor the general public. To some extent they miss both targets," he said. Bouder said this special board should contain risk communication and medical experts and ‘help integrate risk comm